Study Stopped
need to be redesigned
Confirmation of Tube Placement in Newborns
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Tracheal intubation remains a common procedure in the neonatal intensive care unit (NICU) and the delivery room (DR). Current guidelines recommend Estimation of correct endotracheal tube (ETT) insertion Our hospital policy recommends to estimate the correct depth (cm) of tube placement by measuring the nasal-ear-tragus length using the "7-8-9 rule" when the endotracheal tube is placed orally. Using this formula an infant weighing 1kg would be intubated to a depth of 7cm, a 2kg infant to a depth of 8cm, and a 3kg infant to a depth of 9cm from the upper lip. With the new 2015 guidelines, ETT depth is determined by measuring the newborn's nasal septum-tragus length (NTL) and adding 1cm or by using the "initial endotracheal tube insertion depth" table. The NTL is described as the distance from the base of the nasal septum to the tragus of the ear. However, studies using NTL reported that using this technique only resulted in correct ETT placement in 56% of cases. Every ETT has markings on the tube, which are called vocal cord markings, which are to be used to provide a guidance to how deep to place the ETT into the trachea. There has been npc study to compare the vocal cord markings with the current approach of NTL. The current study aims to determine if the use of vocal cord markings during intubation increases percentage of correct endotracheal tube placement compared to NTL in preterm and term infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2022
CompletedFirst Posted
Study publicly available on registry
February 8, 2022
CompletedStudy Start
First participant enrolled
July 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedSeptember 19, 2024
April 1, 2022
2.5 years
January 31, 2022
September 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of endotracheal tubes correctly placed within the trachea
within 30 minutes after endotracheal intubation
Secondary Outcomes (9)
Mortality in the Neonatal Intensive Care Unit
0-200 days
Necrotizing Enterocolitis
0-200 days
Patent Ductus Arteriosus
0-200 days
Intraventricular hemorrhage all grades
0-200 days
Bronchopulmonary Dysplasia at
36 weeks corrected gestational age
- +4 more secondary outcomes
Study Arms (2)
Nostril-Tragus-Length
ACTIVE COMPARATORVocal cord markings
EXPERIMENTALInterventions
Endotracheal tube depth is determined by measuring the newborn's nasal septum-tragus length (NTL) and adding 1cm. The NTL is described as the distance from the base of the nasal septum to the tragus of the ear.
The endotracheal tube has markings on the tube, which are called vocal cord markings, which will be used to provide a guidance to how deep to place the ETT into the trachea.
Eligibility Criteria
You may qualify if:
- All infants (term and preterm) born at The Royal Alexandra Hospital who require endotracheal intubation in the delivery room or/and Neonatal Intensive Care Unit will be eligible.
You may not qualify if:
- Infants will be excluded if their parents refuse to give consent to this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Alexandra Hospital
Edmonton, Alberta, T5H 3V9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Georg Schmolzer
University of Alberta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2022
First Posted
February 8, 2022
Study Start
July 4, 2022
Primary Completion
December 31, 2024
Study Completion
March 31, 2025
Last Updated
September 19, 2024
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
Investigators can contact the PI to discuss to use the collected data